Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial

Authors

Institutions

Publication Details

Journal
The Journal of Urology
Published
2026-02-17
DOI
https://doi.org/10.1097/ju.0000000000004993
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial

Shiwei Zhang, Yuxiang Yin, Wenjie Zhu, Ning Jiang et al.
The Journal of Urology
Bladder and Urothelial Cancer Treatments
article

Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial

Shiwei Zhang, Yuxiang Yin, Wenjie Zhu, Ning Jiang, H. Guo, Danyan Li, Rong Yang, Shun Zhang, Tianhang Li
article en

Abstract

No abstract available for this paper.
The Journal of Urology
Sun Yat-sen University (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), Zhongda Hospital Southeast University (CN), Nanjing Drum Tower Hospital (CN)
Good health and well-being
Openalex Percentile: Top 53%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.